372 related articles for article (PubMed ID: 26397003)
21. Development and validation of an in vivo Candida albicans biofilm denture model.
Nett JE; Marchillo K; Spiegel CA; Andes DR
Infect Immun; 2010 Sep; 78(9):3650-9. PubMed ID: 20605982
[TBL] [Abstract][Full Text] [Related]
22. Polymer multilayers loaded with antifungal β-peptides kill planktonic Candida albicans and reduce formation of fungal biofilms on the surfaces of flexible catheter tubes.
Raman N; Lee MR; Palecek SP; Lynn DM
J Control Release; 2014 Oct; 191():54-62. PubMed ID: 24862322
[TBL] [Abstract][Full Text] [Related]
23. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
Khan MS; Ahmad I
J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
[TBL] [Abstract][Full Text] [Related]
24. How to build a biofilm: a fungal perspective.
Blankenship JR; Mitchell AP
Curr Opin Microbiol; 2006 Dec; 9(6):588-94. PubMed ID: 17055772
[TBL] [Abstract][Full Text] [Related]
25. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
El-Azizi M; Farag N; Khardori N
Ann Clin Microbiol Antimicrob; 2015 Apr; 14():21. PubMed ID: 25885806
[TBL] [Abstract][Full Text] [Related]
26. Digital Design of a Universal Rat Intraoral Device for Therapeutic Evaluation of a Topical Formulation against
Sultan AS; Rizk AM; Vila T; Ji Y; Masri R; Jabra-Rizk MA
Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31527130
[No Abstract] [Full Text] [Related]
27. Candida albicans Biofilms and Human Disease.
Nobile CJ; Johnson AD
Annu Rev Microbiol; 2015; 69():71-92. PubMed ID: 26488273
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Candida Antifungal Resistance Using Animal Infection Models.
Andes DR; Nett JE
Methods Mol Biol; 2023; 2658():225-238. PubMed ID: 37024706
[TBL] [Abstract][Full Text] [Related]
29. Candida albicans Biofilm Development and Its Genetic Control.
Desai JV; Mitchell AP
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185083
[TBL] [Abstract][Full Text] [Related]
30. A rabbit model for evaluation of catheter-associated fungal biofilms.
Chandra J; Long L; Ghannoum MA; Mukherjee PK
Virulence; 2011; 2(5):466-74. PubMed ID: 21921676
[TBL] [Abstract][Full Text] [Related]
31. Biofilm formation by fluconazole-resistant Candida albicans strains is inhibited by fluconazole.
Bruzual I; Riggle P; Hadley S; Kumamoto CA
J Antimicrob Chemother; 2007 Mar; 59(3):441-50. PubMed ID: 17261564
[TBL] [Abstract][Full Text] [Related]
32. Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Chandra J; Mukherjee PK; Leidich SD; Faddoul FF; Hoyer LL; Douglas LJ; Ghannoum MA
J Dent Res; 2001 Mar; 80(3):903-8. PubMed ID: 11379893
[TBL] [Abstract][Full Text] [Related]
33. Candida albicans biofilm development on medically-relevant foreign bodies in a mouse subcutaneous model followed by bioluminescence imaging.
Kucharíková S; Vande Velde G; Himmelreich U; Van Dijck P
J Vis Exp; 2015 Jan; (95):52239. PubMed ID: 25651138
[TBL] [Abstract][Full Text] [Related]
34. The in vitro and in vivo efficacy of fluconazole in combination with farnesol against Candida albicans isolates using a murine vulvovaginitis model.
Bozó A; Domán M; Majoros L; Kardos G; Varga I; Kovács R
J Microbiol; 2016 Nov; 54(11):753-760. PubMed ID: 27796932
[TBL] [Abstract][Full Text] [Related]
35. Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans.
Cui J; Ren B; Tong Y; Dai H; Zhang L
Virulence; 2015; 6(4):362-71. PubMed ID: 26048362
[TBL] [Abstract][Full Text] [Related]
36. Activity of Allyl Isothiocyanate and Its Synergy with Fluconazole against
Raut JS; Bansode BS; Jadhav AK; Karuppayil SM
J Microbiol Biotechnol; 2017 Apr; 27(4):685-693. PubMed ID: 28138121
[TBL] [Abstract][Full Text] [Related]
37. Techniques for antifungal susceptibility testing of Candida albicans biofilms.
Ramage G; López-Ribot JL
Methods Mol Med; 2005; 118():71-9. PubMed ID: 15888936
[TBL] [Abstract][Full Text] [Related]
38. Antifungal susceptibility of Candida albicans in biofilms.
Tobudic S; Kratzer C; Lassnigg A; Presterl E
Mycoses; 2012 May; 55(3):199-204. PubMed ID: 21793943
[TBL] [Abstract][Full Text] [Related]
39. In Vitro Activity of Miltefosine against Candida albicans under Planktonic and Biofilm Growth Conditions and In Vivo Efficacy in a Murine Model of Oral Candidiasis.
Vila TV; Chaturvedi AK; Rozental S; Lopez-Ribot JL
Antimicrob Agents Chemother; 2015 Dec; 59(12):7611-20. PubMed ID: 26416861
[TBL] [Abstract][Full Text] [Related]
40. Strength in numbers: antifungal strategies against fungal biofilms.
Ramage G; Robertson SN; Williams C
Int J Antimicrob Agents; 2014 Feb; 43(2):114-20. PubMed ID: 24359842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
